385 related articles for article (PubMed ID: 29317235)
21. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma.
Park SY; Kim BH; Kim JH; Lee S; Kang GH
Arch Pathol Lab Med; 2007 Oct; 131(10):1561-7. PubMed ID: 17922593
[TBL] [Abstract][Full Text] [Related]
22. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas.
Merchant SH; Amin MB; Tamboli P; Ro J; Ordóñez NG; Ayala AG; Czerniak BA; Ro JY
Am J Surg Pathol; 2001 Dec; 25(12):1515-9. PubMed ID: 11717541
[TBL] [Abstract][Full Text] [Related]
23. [Expression of cytokeratin 7 and 20 in ovarian metastatic carcinomas].
Dai L; Song Q; Li L; Zhong D; Hui Y
Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):114-7. PubMed ID: 11866966
[TBL] [Abstract][Full Text] [Related]
24. Invasive Duct Carcinoma of the Breast With Dominant Signet-Ring Cell Differentiation: A Microsatellite Stable Tumor With Aggressive Behavior.
Chatterjee D; Bal A; Das A; Kohli PS; Singh G; Mittal BR
Appl Immunohistochem Mol Morphol; 2017; 25(10):720-724. PubMed ID: 27153443
[TBL] [Abstract][Full Text] [Related]
25. Morphological features and mucin expression profile of breast carcinomas with signet-ring cell differentiation.
Bartosch C; Mendes N; Rios E; Rodrigues M; Eloy C; Reis CA; Amendoeira I
Pathol Res Pract; 2015 Aug; 211(8):588-95. PubMed ID: 26092598
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas.
Liu H; Shi J; Prichard JW; Gong Y; Lin F
Am J Clin Pathol; 2014 May; 141(5):648-55. PubMed ID: 24713735
[TBL] [Abstract][Full Text] [Related]
27. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung.
Hattori Y; Yoshida A; Yoshida M; Takahashi M; Tsuta K
Pathol Int; 2015 Jun; 65(6):286-92. PubMed ID: 25727644
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical profile of breast cancer with respect to estrogen receptor and HER2 status.
Gloyeske NC; Woodard AH; Elishaev E; Yu J; Clark BZ; Dabbs DJ; Bhargava R
Appl Immunohistochem Mol Morphol; 2015 Mar; 23(3):202-8. PubMed ID: 25356941
[TBL] [Abstract][Full Text] [Related]
30. Gastric metastasis of mammary signet ring cell carcinoma--a differential diagnosis with primary gastric signet ring cell carcinoma.
Yim H; Jin YM; Shim C; Park HB
J Korean Med Sci; 1997 Jun; 12(3):256-61. PubMed ID: 9250925
[TBL] [Abstract][Full Text] [Related]
31. Nonneoplastic signet-ring cell change in gastrointestinal and biliary tracts: a pitfall for overdiagnosis.
Dhingra S; Wang H
Ann Diagn Pathol; 2011 Dec; 15(6):490-6. PubMed ID: 22082777
[TBL] [Abstract][Full Text] [Related]
32. A case of primary signet-ring cell/histiocytoid carcinoma of the eyelid: immunohistochemical comparison with the normal sweat gland and review of the literature.
Iwaya M; Uehara T; Yoshizawa A; Kobayashi Y; Momose M; Honda T; Ota H
Am J Dermatopathol; 2012 Dec; 34(8):e139-45. PubMed ID: 22935888
[TBL] [Abstract][Full Text] [Related]
33. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions.
Lew M; Pang JC; Jing X; Fields KL; Roh MH
Cancer Cytopathol; 2015 Oct; 123(10):576-81. PubMed ID: 26465236
[TBL] [Abstract][Full Text] [Related]
34. Can GATA3 Immunocytochemistry be Utilized as a Reliable Diagnostic Marker for Metastatic Breast Carcinoma in Cytological Materials? A Comparative Study with Mammaglobin and GCDFP-15 Expression.
Hafez NH; Shaaban HM
Turk Patoloji Derg; 2018; 34(2):143-149. PubMed ID: 29235613
[TBL] [Abstract][Full Text] [Related]
35. [Signet ring cell infiltrate in the colon and gastric mucosa].
Grosse-Holz M; Schmidt KD; Seitz G
Pathologe; 2013 Feb; 34(1):74-6. PubMed ID: 23179207
[TBL] [Abstract][Full Text] [Related]
36. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
McCluggage WG; Young RH
Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of mucin expression profiles in breast carcinoma with signet ring cells: a clinicopathological study.
Ohashi R; Hayama A; Yanagihara K; Yamashita K; Sakatani T; Takei H; Naito Z
Diagn Pathol; 2016 Nov; 11(1):131. PubMed ID: 27846863
[TBL] [Abstract][Full Text] [Related]
38. Metastatic signet-ring cell carcinoma of unknown primary origin.
Gregoire C; Muller G; Machiels JP; Goeminne JC
Acta Clin Belg; 2014 Apr; 69(2):135-8. PubMed ID: 24724758
[TBL] [Abstract][Full Text] [Related]
39. Signet ring cell lobular carcinoma of the breast presenting in a cervicovaginal smear. A case report.
Pambuccian SE; Bachowski GJ; Twiggs LB
Acta Cytol; 2000; 44(5):824-30. PubMed ID: 11015987
[TBL] [Abstract][Full Text] [Related]
40. CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.
Chiesa-Vottero A
Int J Gynecol Pathol; 2020 Mar; 39(2):170-177. PubMed ID: 32045390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
